🇺🇸 FDA
Patent

US 7605127

Truncated hepatocyte growth factor variant protein HGF/NK2

granted A61KA61K38/193

Quick answer

US patent 7605127 (Truncated hepatocyte growth factor variant protein HGF/NK2) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K38/193